6 June 2022 in Research, Society and Development
Purpose: The objective of this study was to evaluate the effects of Gamma irradiation by simulating a total dose of conventional head and neck cancer radiotherapy on bone remodeling and osseointegration of implants in femurs of rats.Materials and Methods: Sixty rats received threaded titanium (Ti6Al4V) implants in both femurs. The animals were divided: No-Irradiation (N-Ir): N-Ir group with implant solely, Early-Irradiation (E-Ir): implant + irradiation after 24hrs.; Late-Irradiation (L-Ir): implant + irradiation after 4 weeks and Previous-Irradiation (P-Ir): irradiation + implant after 4 weeks. Irradiation was fractioned in two sessions of 15 Gy each, totaling 30 Gy. The animals were euthanized at 3 days, 2 and 7 weeks after treatment, which were chosen from previous studies. Runx2 immunohistochemical markers and Picrosirius red stain, histomorphometric analysis (BIC and BAFO) and reverse torque test were used to evaluate the implant/bone interface and surrounding bone. Data of Runx-2 (%), picrosirius red stain (%), BIC and BAFO (%), and reverse torque (N/cm) was submitted to ANOVA and Tukey tests for comparison among groups, both with α=0.05. Results: The results showed that Runx-2 expression was different in irradiated groups when compared to N-Ir group. In general, the collagen fiber analyses in the irradiated groups differed from the N-Ir group. Regarding BIC, BAFO, and the reverse torque test, the L-Ir group demonstrated results similar to the N-Ir group, while the others groups were impaired by radiotherapy. Conclusions: Ionizing radiation negatively affected bone remodeling, and its effect depends on when radiotherapy is applied, with a delay of osseointegration when applied previously or close to surgery.
30 April 2019 in Brazilian Dental Science
Objective: To measure the intensity of muscle strength and electrical activity of masseter and anterior temporal muscles based on BTX-A therapy in patients rehabilitated with total prostheses on zygomatic implants. Material and Methods: The object of the study was a sample of 20 individuals subjected to zygomatic implant surgery and rehabilitated with implant-supported prostheses, in order to obtain electromyographic data using an eight-channel module (EMG System do Brasil). The data were collected for three consecutive months: prior to the application (single dose) of BTX-A (30 U/ masseter muscle; 10 U/temporal muscle) and after 30 and 90 days of therapeutic treatment. Result: All muscle groups studied showed reduction of muscle electrical activity during voluntary contraction after 30 days of treatment (around 47%) (p < 0.001), which progressively reverted after 90 days of treatment. The anterior temporal muscles presented similar motor behavior, with activity reduction of 39% (p < 0.05). There was a reduction of 17.68% (p < 0.05) in mandibular force and an increase of 14.22% (p < 0.05) in mouth opening after 30 days of BTX-A administration. Conclusions: The results suggest that BTX-A significantly reduces muscle activity, in either the recruitment of motor units or muscle tone, in the first three months of therapeutic treatment. This therapy may also be useful as a preventive method for the failure of zygomatic implant-supported prostheses.KeywordsElectromyography; Dental implants; Prostheses on implants; Botulinum toxin.Keywords: Electromyogra phy; Dental implants; Prostheses on implants; Botulinum toxin.